Speakers

Sort by
Newest
Trending
1-14 of 14
Filter
Priscilla Agoncillo
Co-Founder at Original Breeders League
anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis industry, democratic party (united states), dispensary, dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, food and drug administration, free market, gerrymandering, good manufacturing practice, hair loss, health care, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, mood stabilizer, neuroplasticity, neurotransmitter, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, selective serotonin reuptake inhibitor, sense, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression
Dean Johnson
President at Applied Botanics
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Daniel Sliva
CSO & Founder at DSTest Laboratories
allosteric regulation, anti-inflammatory, antiviral drug, aspirin, assay, attention, bioavailability, biology, blinded experiment, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabidiol is, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cardiovascular disease, cell signaling, chemical substance, chemistry, chromatography, chronic pain, cigarette, clinical trial, clinicaltrials.gov, coffee, coffee bean, common sense, coronavirus disease 2019, crisis management, diesel fuel, dietary supplement, direct-to-consumer advertising, distillation, dose (biochemistry), drug, drug test, end-user, endocannabinoid system, experiment, first, pass effect, flax, food, food and drug administration, fraud, gastrointestinal tract, germination, good manufacturing practice, green tea, hemp, hepatotoxicity, high-performance liquid chromatography, hospital, ibuprofen, in vitro, infection, inflammation, innovation, insomnia, intravenous therapy, iso/iec 17025, knowledge, laboratory, ligand (biochemistry), lipid, marketplace, medication, melatonin, micro-encapsulation, mining, molecule, nabiximols, nanoparticle, national institutes of health, nutraceutical, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, organ transplantation, osteoarthritis, packaging and labeling, pain, paracetamol, peripheral neuropathy, petroleum, pharmaceutical industry, pharmacokinetics, pharmacology, psychoactive drug, randomized controlled trial, reason, receptor (biochemistry), recycling, reliability engineering, research, right to know, risk, route of administration, sense, serotonin, sleep disorder, social supports, steam distillation, steve jobs, supercritical fluid, taste, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, the end-user, thin-layer chromatography, toxicity, vitamin, warranty, waste, water, women's health
Evan Ogburn
Founder at PHARM CBD
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Thomas Howard
Co Host at Cannabis Legalization News
anti-inflammatory, antidepressant, anxiolytic, bank, bodyguard, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), credit card, crime, democratic party (united states), electronic cigarette, entourage effect, fence (criminal), financial crime, food and drug administration, gerrymandering, hsbc, jpmorgan chase, major depressive disorder, mastercard, mechanism of action, medical cannabis, medication, money laundering, neuroplasticity, neurotransmitter, paypal, pharmacology, post-traumatic stress disorder, price, psilocybin, psilocybin mushroom, psychedelic drug, sense, serotonin, suspicious activity report, swing state, tetrahydrocannabinol, underwriting, united states department of agriculture, united states postal service, visa inc.
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Stephen Cutter
Founder & CEO at Hemp for the Future
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Randy Reed
Cannabis Scientist & Manufacturing Engineer at Lehua Brands
adolescence, apple, bicycle, biochar, biodiesel, biotechnology, brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, concept, cultivar, curveball, drink, electronic cigarette, engineer, entourage effect, farm, farmer, feeling, food, good manufacturing practice, hemp, market (economics), medical cannabis, medication, occupational safety and health, phenotype, quality management system, race (human categorization), reverse engineering, sense, slider (baseball), supermarket, terpene, terroir, tetrahydrocannabinol, washington (state), whole foods market
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Bryant Jones
Plant Scientist, Herbalist at University Of Minnesota
1996 california proposition 215, adolescence, agriculture, agronomy, american chemical society, amino acid, aphid, attention, automation, bacteria, bicycle, biological pest control, biotechnology, blinded experiment, brand, candy, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis cultivation, cannabis indica, cannabis sativa, carbon dioxide in earth's atmosphere, carbon sequestration, charlotte's web (cannabis), chemist, chemistry, clay, clinicaltrials.gov, coffee, coffee bean, concept, consumer confidence, coronavirus disease 2019, crop rotation, cultivar, cultivator, curveball, decomposition, diesel fuel, dietary supplement, distillation, dna sequencing, dominance (genetics), drink, due diligence, ecology, ecosystem, education, endocannabinoid system, engineer, entourage effect, experience, farmer, farmers' market, fda warning letter, fertigation, fertilizer, food and drug administration, fungus, gardening, gene, generally recognized as safe, genetically modified crops, genetically modified food, genetically modified organism, genetics, genomics, germination, glyphosate, good manufacturing practice, grasshopper, greenhouse, gummy candy, hamburger, hash oil, health claim, hemp, herb, heterosis, hospital, hot chocolate, ibuprofen, impatiens necrotic spot virus, in vitro, infection, innovation, insect, integrated pest management, interdisciplinarity, ion, ion-exchange, irrigation, irrigation in viticulture, laboratory, lavandula, lawyer, learning, maize, market (economics), mediation, medical cannabis, medication, medicinal plants, microbiota, microorganism, mind, molecule, monopoly, mycorrhiza, natural environment, natural resource, natural selection, news, nitrate, nitrite, nitrogen, no-till farming, nonprofit organization, nutrient, nutrition, organic certification, organic farming, organic matter, over-the-counter drug, pansy, password, pathogen, pest control, pesticide, pharmaceutical industry, pharmacokinetics, pharmacovigilance, phenotype, phloem, photorespiration, photosynthesis, phytochemical, plant breeding, plant nursery, plant tissue culture, plant virus, question, race (human categorization), randomized controlled trial, recycling, research and development, research, and development, retail, reverse engineering, root, sales, sampling (statistics), scott gottlieb, sense, silt, slider (baseball), smoking, social media, social stigma, soil, soul, soybean, steam distillation, sucrose, supercritical fluid, supply chain, surface runoff, sustainability, technology, terpene, tetrahydrocannabinol, time, tomato, traceability, transpiration, tree, united states department of agriculture, united states farm bill, vegetative reproduction, videotelephony, virus, vitis, washington (state), water, weed, wheat, women's health, xylem
Shea Alderete
Founder at GenX Biotech
adolescence, automation, bicycle, biotechnology, blood, brand, cannabidiol, cannabinoid, cannabis, cannabis indica, coffee, concept, cookware and bakeware, curveball, dose (biochemistry), drink, electronic cigarette, engineer, entourage effect, environmental remediation, good manufacturing practice, market (economics), medical cannabis, mind, pesticide, plastic pipework, potato cannon, prescription drug, race (human categorization), recreational drug use, reverse engineering, rosin, science, sense, slider (baseball), soft drink, starbucks, supply chain, terpene, tetrahydrocannabinol, valve, washington (state), whiskies, whisky
Tristan Watkins
Chief Science Officer (CSO) at LucidMood
23andme, adolescence, aromatherapy, aromaticity, bicycle, biotechnology, brand, budtender, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chromium, concept, creativity, curveball, dietary supplement, disease, dose (biochemistry), drink, electronic cigarette, engineer, entourage effect, epilepsy, food, food and drug administration, genetics, good manufacturing practice, hemp, herbal medicine, inflammation, insomnia, ligand (biochemistry), limonene, market (economics), medical cannabis, medication, medicine, memory, mind, pharmaceutical industry, placebo, questionnaire, race (human categorization), relaxation (psychology), reverse engineering, route of administration, science, sedative, sense, slider (baseball), synergy, terpene, tetrahydrocannabinol, time, traditional chinese medicine, washington (state), zolpidem
1